Category: Biotechnology
Biotechnology market research reports by Plunkett Research, Ltd.
-
Financial Analysis and Multi-Year Benchmarking: Moderna Inc (MRNA:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Moderna Inc (MRNA:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Moderna Inc (MRNA:NAS). Includes Industry Averages & Top Competitors, ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Fate Therapeutics Inc (FATE:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Fate Therapeutics Inc (FATE:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Fate Therapeutics Inc (FATE:NAS). Includes Industry Averages ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Bionano Genomics Inc (BNGO:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Bionano Genomics Inc (BNGO:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Bionano Genomics Inc (BNGO:NAS). Includes Industry Averages & ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Yield10 Bioscience Inc (YTEN:PINX). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Yield10 Bioscience Inc (YTEN:PINX). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Yield10 Bioscience Inc (YTEN:PINX). Includes Industry Aver ... Read More
-
Financial Analysis and Multi-Year Benchmarking: United Therapeutics Corporation (UTHR:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: United Therapeutics Corporation (UTHR:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: United Therapeutics Corporation (UTHR:NAS). Includ ... Read More
-
Financial Analysis and Multi-Year Benchmarking: XOMA Corporation (XOMA:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: XOMA Corporation (XOMA:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: XOMA Corporation (XOMA:NAS). Includes Industry Averages & Top Com ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Northwest Biotherapeutics Inc (NWBO:PINX). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Northwest Biotherapeutics Inc (NWBO:PINX). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Northwest Biotherapeutics Inc (NWBO:PINX). Includes ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Sangamo Therapeutics Inc (SGMO:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Sangamo Therapeutics Inc (SGMO:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Sangamo Therapeutics Inc (SGMO:NAS). Includes Industry Av ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Charles River Laboratories International Inc (CRL:NYS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Charles River Laboratories International Inc (CRL:NYS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Charles River Laboratories Internation ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Amgen Inc (AMGN:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Amgen Inc (AMGN:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Amgen Inc (AMGN:NAS). Includes Industry Averages & Top Competitors, KPIs ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Nektar Therapeutics (NKTR:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Nektar Therapeutics (NKTR:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Nektar Therapeutics (NKTR:NAS). Includes Industry Averages & T ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Agilent Technologies Inc (A:NYS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Agilent Technologies Inc (A:NYS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Agilent Technologies Inc (A:NYS). Includes Industry Averages ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Myriad Genetics Inc (MYGN:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Myriad Genetics Inc (MYGN:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Myriad Genetics Inc (MYGN:NAS). Includes Industry Averages & T ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Anika Therapeutics Inc (ANIK:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Anika Therapeutics Inc (ANIK:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Anika Therapeutics Inc (ANIK:NAS). Includes Industry Averag ... Read More
-
Revenue Forecasts to (2031) and Analytics for the Vaccines, Skin Replacement Products and Biologicals Manufacturing (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325414
Revenue Forecasts to (2031) and Analytics for the Vaccines, Skin Replacement Products and Biologicals Manufacturing (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325414 Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save co ... Read More
-
Revenue Forecasts to (2031) and Analytics for the Chemicals, Specialty Manufacturing, Including Fragrances, Silicones, Biodiesel & Enzymes (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325199
Revenue Forecasts to (2031) and Analytics for the Chemicals, Specialty Manufacturing, Including Fragrances, Silicones, Biodiesel & Enzymes (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325199 Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and fore ... Read More
-
Plunkett's Health Care Industry Almanac 2025: Health Care Industry Market Research, Statistics, Trends and Leading Companies
PLUNKETT'S HEALTH CARE INDUSTRY ALMANAC 2025 Key Findings: A complete market research report, including forecasts and market estimates, technologies analysis and developments at innovative firms within the Health Care Industry. Gain vital insights that can help shape strategy for business developme ... Read More
-
Financial Analysis and Multi-Year Benchmarking: ImmunoPrecise Antibodies Ltd (IPA:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: ImmunoPrecise Antibodies Ltd (IPA:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forImmunoPrecise Antibodies Ltd ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Replicel Life Sciences Inc (RP:TSX). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Replicel Life Sciences Inc (RP:TSX). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forReplicel Life Sciences Inc (RP: ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Lexaria Bioscience Corp (LEXX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Lexaria Bioscience Corp (LEXX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forLexaria Bioscience Corp (LEXX:NA ... Read More
-
Plunkett's Biotech, Pharmaceuticals & Genetics Industry Almanac 2025: Biotech, Pharmaceuticals & Genetics Industry Market Research, Statistics, Trends and Leading Companies
PLUNKETT'S BIOTECH, PHARMACEUTICALS & GENETICS INDUSTRY ALMANAC 2025 Key Findings: A complete market research report, including forecasts and market estimates, technologies analysis and developments at innovative firms within the Biotech, Pharmaceuticals & Genetics Industry. Gain vital insights tha ... Read More
-
Vaccines, Skin Replacement Products and Biologicals Manufacturing (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2030, NAIC 325414
Vaccines, Skin Replacement Products and Biologicals Manufacturing (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2030, NAIC 325414 Vaccines, Skin Replacement Products and Biologicals Manufacturing Industry (U.S.): Analytics, Extensive Financial Metrics, Benchmark ... Read More
-
Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2030, NAIC 325412
Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2030, NAIC 325412 Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing Industry (U.S.): Analytics, Extensive Financial Metrics, Ben ... Read More
-
Basic Organic Chemical Manufacturing, Including Petrochemical Intermediates, Silicone, Ethanol, Plasticizers and Enzyme Proteins (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2030, NAIC 325190
Basic Organic Chemical Manufacturing, Including Petrochemical Intermediates, Silicone, Ethanol, Plasticizers and Enzyme Proteins (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2030, NAIC 325190 Basic Organic Chemical Manufacturing, Including Petrochemical Interme ... Read More
-
Scientific Research and Development (R&D) in Physics, Engineering, Life Sciences, Drugs, Telecommunications and Electronics (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2030, NAIC 541710
Scientific Research and Development (R&D) in Physics, Engineering, Life Sciences, Drugs, Telecommunications and Electronics (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2030, NAIC 541710 Scientific Research and Development (R&D) in Physics, Engineering, Life Sc ... Read More
Research Assistance
